Maker of Truenat — the world-first battery-operated, chip-based point-of-care real-time PCR platform, WHO-endorsed as the initial test for TB and MDR-TB and used across 40+ assays including hepatitis, dengue, malaria, influenza and COVID-19. R&D is driven by its wholly-owned subsidiary Bigtec Labs. During India's 100-day TB campaign, Truenat combined with AI-enabled handheld X-ray screened over 12 crore people; India has built a network of 8,000+ NAAT systems using Truenat, moving away from reliance on imported GeneXpert systems. Cited by PM Modi as a Make in India success story. Manufacturing at Verna Industrial Estate, Goa.
Battery-operated, portable real-time quantitative micro PCR analyzers (1/2/4-channel) running any Truenat chip — sample-to-result in about 1 hour with real-time SMS/email data transfer.
Chip-based real-time PCR tests for TB (incl. rifampicin/isoniazid resistance), HIV, HBV/HCV/HAV/HEV, dengue, chikungunya, malaria, influenza A/B, H1N1 and more — 40+ assays on one platform.
Fully automatic cartridge-based nucleic acid extraction and purification device, ~20-minute extraction from CSF, blood, sputum, urine, swab and other specimen types.